AIM ImmunoTech Inc (NYSE American:AIM)
| 2.13 Delayed Data As of Oct 23 |  +0.05 / +2.40%Today’s Change | 0.38 Today|||52-Week Range 7.11 | +291.54% Year-to-Date |
Latest AIM News | Press Releases
No recent news for AIM ImmunoTech Inc.
Today’s Trading
| Previous close | 2.08 |
| Today’s open | 2.27 |
| Day’s range | 2.05 - 2.12 |
| Volume | 684,198 |
| Average volume (3 months) | 4,654,856 |
| Market cap | $84.1M |
Data as of 3:46pm ET, 10/23/2020
Growth & Valuation
| Earnings growth (last year) | +73.22% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -61.85% |
| P/E ratio | 2.9 |
| Price/Sales | 14.15 |
| Price/Book | 1.82 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CRBPCorbus Pharmaceutica... | -0.02 | -1.92% |
| EYENEyenovia Inc | +0.04 | +1.15% |
| KTOVKitov Pharma Ltd | +0.25 | +5.59% |
| BLPHBellerophon Therapeu... | -0.03 | -0.33% |
Data as of 4:00pm ET, 10/23/2020
Financials
| Next reporting date | November 12, 2020 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $140.0K |
| Annual profit (last year) | -$9.5M |
| Net profit margin | -6,809.29% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Ocala, Florida |
Forecasts
